Methods for indentifying markers for early-stage human cancer, cancer progression and recurrence

Details for Australian Patent Application No. 2006299539 (hide)

Owner AntiCancer, Inc. National Institutes of Health

Inventors Kopelovich, Levy; Xu, Mingxu; Tan, Yuying

Agent Davies Collison Cave

Pub. Number AU-A-2006299539

PCT Pub. Number WO2007/041472

Priority 60/722,594 30.09.05 US

Filing date 29 September 2006

Wipo publication date 12 April 2007

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C40B 40/04 (2006.01) Libraries , e.g. arrays, mixtures - Libraries containing only organic compounds

C40B 40/08 (2006.01) Libraries , e.g. arrays, mixtures

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041472 Priority application(s): WO2007/041472

6 November 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read from Methods for indentifying markers for early-stage human cancer, cancer progression and recurrence to Methods for identifying markers for early-stage human cancer, cancer progression and recurrence

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299541-Call waiting for a teleconference system

2006299521-Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist